The extent to which differentiated cells, while remaining in their native microenvironment, can be reprogrammed to assume a different identity will reveal fundamental insight into cellular plasticity and impact regenerative medicine. To investigate in vivo cell lineage potential, we leveraged the zebrafish as a practical vertebrate platform to determine factors and mechanisms necessary to induce differentiated cells of one germ layer to adopt the lineage of another. We discovered that ectopic co-expression of Sox32 and Oct4 in several non-endoderm lineages, including skeletal muscle, can specifically trigger an early endoderm genetic program in a cell-autonomous manner.
Introduction
In animals, from flat worms to humans, nearly all cell lineages develop from one of three germ layers, established during the earliest stages of development. Despite several hundred millions of years of evolution, the type of specialized cells (i.e., neuronal, muscle, or pancreatic cells) that can develop from each of the distinct germ layers (ectoderm, mesoderm, or endoderm, respectively), remain well conserved among highly divergent animals, suggesting that lineage identities are restricted to specific germ layers. This paradigm is consistent with the prevailing interpretation of the Waddington's epigenetic landscape 1 model suggesting that during animal development, a cell's lineage potential becomes increasingly restricted as they differentiate.
Furthermore, lineage restriction within germ layers appears to also apply to induced in vivo cell lineage reprogramming of vertebrate cells, as directed lineage transdifferentiation has only been shown among cell types from the same germ layer 2 . However, in the invertebrate roundworm Caenorhabditis elegans, it was demonstrated that two specific non-endoderm cell lineages, can be artificially converted into intestinal cells, which are normally of endoderm origin 3 . It remains unclear whether in vivo intergerm layer lineage conversion is unique to these cell types or to this and other invertebrates 4 . The ability to directly reprogram a differentiated vertebrate cell identity in vivo, without spatial or lineage limitations, would indicate that the developmental origin of a cell and its natural microenvironment does not absolutely limit its potential identity, challenging the dogma of in vivo developmental lineage restriction and opening potential new avenues for regenerative medicine.
In vivo platform to identify endoderm inducing factors
To investigate whether stably differentiated vertebrate cells can be lineage converted in vivo into unrelated cell types (across germ layers and in distinct microenvironments), we leveraged the zebrafish embryo. This animal model is highly amenable to transgenic modification, and due to its rapid embryonic development, functionally differentiated muscle cells are already present at 24 hpf (hours post fertilization), as indicated by a beating heart and body movements. We aimed to induce endoderm lineages from differentiated, non-endoderm-derived cells and in tissues not closely localized to gut endoderm derived tissues. Unlike differentiated cells originating from the mesoderm and ectoderm which are often intermingled, differentiated cells of the endoderm lineage remain largely contiguous with the gut tube, facilitating the identification of ectopically induced endoderm cells in non-endoderm derived tissues.
In contrast to previous in vivo reprogramming strategies to induce a specific endoderm cell type 5 or a pluripotent intermediate, our novel strategy is to trigger the early endoderm genetic program. With this approach, we predict that early-endoderm induced cells will have the developmental potential to progress towards various endoderm lineages and ultimately adopt distinct endoderm cell fates. Zygotes were injected with DNA constructs containing candidate endoderm specification genes (individually or in combination) driven by the heat shock inducible hsp70l promoter 6 , allowing for temporally controlled, transient, and spatially mosaic transgene expression throughout the fish ( Fig.1A-A" ). With this approach, transgene expression levels will vary extensively between cells due to variable transgene dose. Therefore, this in vivo platform allows for highly diverse conditions of transgene expression, in a variety of different cell types, and at different states of differentiation, thereby enhancing the chance of discovering factors with lineage conversion potential.
sox32 and oct4 were both previously shown to be required during zebrafish gastrulation for normal endoderm lineage specification [7] [8] [9] . With induction beginning at 24 hpf, we found that expression of either zebrafish sox32 (hsp70l:H2BmCherry-P2A-sox32) or mouse Oct4 (pou5f3;
hsp70l:mCherryCAAX-P2A-Oct4) alone failed to significantly induce ectopic expression of sox17 (sox17:GFP), the earliest definitive endoderm marker in fish and mammals 10 ( Figure 1B Figure 1 ). Upon closer examination of sox17:GFP-positive cells within the myotomes, we found that most have multiple nuclei and an elongated and striated cell morphology (see Figure 1D' ). These cells also coexpressed the transgene reporters for both sox32 (nuclear mCherry) and Oct4 (membrane mCherry), indicating that differentiated skeletal muscle cells can be cell-autonomously induced by Sox32 and Oct4 to express sox17. Because sox17 is also expressed in a sub-population of endothelial cells during development, we examined endothelial markers and found no ectopic induction of fli1a:GFP or kdrl:GFP (Supplement Figure 2A -D') in muscle cells of the myotome, suggesting that the ectopically induced sox17 expression does not indicate endothelial identity, but more likely endoderm. Further, forced coexpression of both sox32 and Oct4 can also cellautonomously induce ectopic foxa3 (foxa3:GFP), a gene normally expressed in a broad subset of the endoderm ( Figure 1E -E'). Consistent with normal endoderm development, we find that ectopic foxa3:GFP expression appeared later than sox17. These results indicate that Sox32 and Oct4 can intrinsically induce the earliest genetic markers of the endoderm lineage. Our finding that the combination of mouse (and human; not shown) Oct4 with zebrafish Sox32 can induce sox17:GFP and foxa3:GFP expression in fish also supports a conserved genetic mechanism for induction of endoderm lineage specification between fish and mammals.
To increase the number of cells expressing both Oct4 and Sox32, the coding sequence for each factor, in addition to mCherry, were placed within the same polycistronic construct, downstream of the hsp70l promoter (hsp70:Oct4-P2A-mCherry-P2A-sox32). Using this expression construct, we found ectopic sox17:GFP in p63 expressing cells (epidermal) and Elavl3/4 expressing cells (neuronal) suggesting that cells originating from the surface ectoderm and neural ectoderm, respectively, can be induced by Sox32 and Oct4 to express sox17 (Supplement Figure 1A -B"). To further investigate in vivo genetic and cellular changes induced by ectopic expression of these genes, we focused our analysis on skeletal muscle cells in the trunk of the animals. Differentiated skeletal muscle cells can be identified based on their elongated shape, striations, and multiple, regularly spaced nuclei, and are abundantly found in a consistent, parallel pattern spanning individual myotomes. The appearance of ectopic sox17:GFP and foxa3:GFP expression in muscle cells with these characteristics suggests that differentiated cells are indeed being induced to activate expression of these early endoderm genes, and further suggests that a complete loss of muscle morphology and cell division is not a prerequisite for their induction. However a subset of skeletal muscle cells expressing Oct4 and sox32 transgenes do exhibit variable loss of muscle morphology, including partial or complete loss of striation and elongated cell shape, and adopting a more stellate shape ( Figure 1E and J). Interestingly, the nuclei in reporgrammed muscle cells appear to aggregate together towards the center of the cell (n=20/22 cells; Supplement Figure 3 ), reminiscent of striated muscle regeneration 11 . Live imaging from 48 to 72 hpf, using light sheet microscopy, shows highly dynamic changes in cell morphology (Supplement Movie 1). In particular, some muscle cells appear to be separating into two individual cells, potentially becoming mononucleated ( Figure 1I -I"; white and yellow arrows, Supplement Movie 2). Further, we observed that cells with induced sox17:GFP form cellular extensions in multiple directions. Intriguingly, mCherry expression can be rapidly cleared, suggesting an active process for protein turnover in cells that are being reprogrammed ( Figure 1J Figure 4 ). Rapid turnover of structural proteins such as Myosin would explain the rapid loss of the skeletal muscle morphology, as these cells are dense with structural proteins necessary for their elongated shape and striations.
To investigate whether induced muscle cells with sox17:GFP expression function like early endoderm and progress in a development-like manner, we examined later markers of endoderm regionalization and organogenesis. Endogenous endoderm sox17 mRNA expression is temporally restricted to a short time window before the end of gastrulation (~7-10 hpf) and is therefore not coexpressed with later endoderm genes 12 . Consistent with the early and brief duration of sox17 transcript expression observed in normal endoderm development, ectopic sox17 mRNA expression was limited to within the initial several hours following heat shock induction of the Oct4 and sox32 transgenes (not shown). However, perdurance of GFP allows for examination of sox17:GFP-positive cells beyond the loss of ectopic sox17 transcript expression. By 48 hpf, sox17:GFP-positive cells in the myotome can be found to coexpress transcripts of the foregut endoderm gene foxa2 and pancreas specification genes, hhex and ptf1a ( Figure 1F -H).
In contrast, transcripts specific to muscles such as myh7 (myosin heavy chain 7) mRNA are lost from most sox17:GFP positive muscle cells (Supplement Figure 4A -B"). These findings suggest that ectopic Oct4 and sox32 expression can inhibit muscle specific transcripts while triggering the endoderm developmental genetic program.
The early endoderm genetic program is specifically triggered while muscle gene expression is lost
To express transgenes in a specific type of differentiating skeletal muscle cell, the mylpfa (myosin light chain, phosphorylatable, fast skeletal muscle a) promoter 13 was used to drive Oct4 and Sox32 expression ( Figure 2A ). With a construct containing the mylpfa promoter driving mCherry alone, we confirmed that the activity of this promoter is almost exclusively restricted to fast muscle cells (and not found in non-skeletal muscle cells) in injected embryos ( Figure 2B To more broadly assess transcriptional changes induced in reprogrammed muscle cells, we pooled sorted mCherry-positive cells from fish injected with either the mylpfa promoter driving mCherry alone (control) or together with Oct4 and sox32, and carried out qPCR analysis.
Consistent with our histological studies using fluorescent reporter lines and whole mount in situ hybridization, early and late endoderm genes, sox17, foxa2, hnf1ba, hnf4a, and ptf1a mRNA expression are all significantly upregulated in sorted muscle cells with sox32 and Oct4 transgene expression ( Figure 2G , Supplement Figure 5 ). These results suggest that in fast muscle cells, the endoderm specification genes sox32 and Oct4 can trigger genetic programs for multiple endoderm lineages. We also examined markers of other germ layers to determine the specificity of the endoderm induction. Mesoderm genes, tbxta (T; brachyury) and meox1, surface ectoderm genes, foxi1 and p63, and neural ectoderm genes, sox1a, zic2.2, and others, are not upregulated, suggesting neither mesoderm or ectoderm lineages are induced ( Figure 2G ). However, we found that the muscle genes myod, myhz2, tnnt3a, and mylpfa are downregulated, consistent with the loss of muscle cell morphology and myosin protein/mRNA expression described above. Together, these gene expression studies indicate that forced expression of sox32 and Oct4 in fast skeletal muscle cells leads to a loss of the muscle genetic program and to a specific activation of the endoderm genetic program.
Induced endoderm cells proceed through a developmental mechanism to express pancreatic gene ptf1a
To explore the mechanism by which the induced endoderm (iEndo) cells proceed to express later organogenesis genes, we focused on reprogrammed muscle cells with ectopic expression of the pancreas specification gene ptf1a. Misexpression of sox32 and Oct4 can lead to muscle cells with ptf1a:GFP by 48-72 hpf in about one in five injected embryos. iEndo muscle cells with ectopic ptf1a:GFP are most often found in the posterior third of the fish. The low frequency and spatial propensity of induced ptf1a:GFP expression led us to posit that only certain iEndo cells with optimal intrinsic (intracellular) and extrinsic (extracellular/microenvironment) conditions will proceed toward a specific endoderm lineage pathway such as a liver, intestine, or pancreatic genetic program. The skeletal muscle microenvironment has previously been demonstrated to be permissive for human pancreas cell differentiation and function [14] [15] [16] [17] . Because neuronal genes are not induced, the ectopic ptf1a expression observed is unlikely to represent the normal cerebellar or retinal domains of ptf1a expression. Furthermore, because iEndo muscle cells with ectopic ptf1a expression can be found to coexpress sox17:GFP (see Figure 1H ), they are more likely to be pancreatic endoderm. However, a lack of late pancreatic genes in these cells indicates that conditions are suboptimal for further differentiation.
The temporal sequence of endoderm genes expressed in iEndo cells appears to recapitulate that of endogenous endoderm development, leading us to functionally assess whether the ectopic ptf1a expression occurred via a genetic pathway analogous to normal development. FGF signaling was shown to be necessary for foregut endoderm cells to adopt ventral pancreatic endoderm lineage in normal zebrafish development and in human stem cells differentiation models 18, 19 . Further, FGF signaling is highest posteriorly where ectopic ptf1a:GFPpositive muscle cells are most often observed 20 . Blocking FGF receptor tyrosine kinase signaling with the inhibitor SU5402 prevents iEndo muscle cells and endogenous foregut endoderm from expressing ptf1a:GFP but does not prevent ectopic sox17:GFP ( Figure 3A -F"). These findings suggest that iEndo cells do not spontaneously express ptf1a, but rather proceed through a stepwise genetic program resembling normal, Fgf signaling dependent, pancreas development.
Pluripotency is not required for in vivo induced endoderm
Examples of in vivo cell lineage plasticity, including natural transdifferentiation in worms, fin regeneration in zebrafish, and maintenance of the neural crest lineage potential in frogs, have implicated a pluripotency mechanism [21] [22] [23] . These findings led us to ask whether our induction of muscle into endoderm lineage conversion using Oct4 and Sox32 also involves a pluripotency mechanism. The lack of induction of the skeletal muscle progenitor genes pax3 and pax7 ( Figure   2G ), suggests that lineage conversion does not involve the dedifferentiation of skeletal muscle cells. The appearance of endoderm gene expression prior to loss of muscle morphology suggests that cell division is not required for iEndo cells. Consistently, inhibition of cell proliferation with aphidicolin does not prevent the induction endoderm transcripts by sox32 and Oct4 (not shown).
Together with a lack of mesoderm and ectoderm gene activation, we posit that lineage conversion of muscle to endoderm does not involve a pluripotent intermediate. Consistently, qPCR expression analysis does not show upregulation of standard pluripotent mRNA markers, including endogenous oct4, myca, vasa, or nanog ( Figure 2G ). However, it may be possible that Oct4 functions as a pluripotent factor without requiring the iEndo cells to have gone through a detectable pluripotent intermediate. Mammalian Oct4, in combination with other Yamanaka factors, was previously shown to be able to reprogram fish cells in culture to pluripotency 24 . To assess the requirement of Oct4's pluripotency function for reprogramming muscle into endoderm in vivo, we used a modified form of Oct4 which has an amino acid substitution in the linker domain, previously shown to be transcriptionally active but unable to induce pluripotency (Oct4(L80A); Figure 4A ) 25 . As with wild-type Oct4, mis-expression of mutant Oct4(L80A) with Sox32 (hsp70:Oct4(L80A)-P2A-mCherry-P2A-sox32) can induce muscle cells to express sox17:GFP, as well as lead to cell shape changes ( Figure 4B-B") . Moreover, like wild type Oct4 iEndo cells, these Oct4(L80A) iEndo cells can also proceed to exhibit ptf1a:GFP expression and lose myosin ( Figure   4C -E",Supplemental Figure 3F -F"), suggesting that they can progress towards a pancreas developmental genetic program, while rapidly losing muscle protein expression. These findings demonstrate that a robust pluripotency mechanism via Oct4 is not required to induce muscle cells into early endoderm-like cells, further supporting our conclusion that in vivo lineage conversion across germ layers can be induced directly, independent of a pluripotent intermediate. This finding also functionally demonstrates for the first time, that Oct4's roles in endoderm specification may be distinct from its well defined role in pluripotency.
Discussion
Within a vertebrate embryo, we demonstrate that differentiated mesoderm-derived skeletal muscle cells can be induced with ectopic expression of just two transcription factors, Sox32 and Oct4, to cell-autonomously trigger early endoderm-like development. These early endoderminduced cells can rapidly lose muscle cell morphology and gene expression while transitioning through an endoderm genetic program resembling normal endoderm development. This lineage conversion process appears to be direct as no evidence was found to support a pluripotent or dedifferentiated intermediate state. As with normal endogenous pancreatic ptf1a expression, expression of ptf1a in iEndo muscle cells also requires Fgf signaling. Expression of ptf1a, in addition to other endoderm organogenesis specification factors, shows that these iEndo cells can function to give rise to diverse endoderm lineage genetic programs. Expression of organogenesis markers also suggests the potential for these iEndo to be further coaxed, with additional factors, into a specific functional differentiated endoderm organ cell type such as pancreatic beta-cells, which would be useful for diabetics.
Waddington's epigenetic landscape model suggests that as cells differentiate during normal development, they become more restricted from adopting other lineage identities. However, requiring only a few transcription (intrinsic) factors, transdifferentiation across germ layers using in vitro approaches has proven to be surprisingly easier than the Waddington model would predict, challenging this paradigm of limited lineage potential 26 But similar to MEFs, differentiated cells at developmental stages are presumably more amenable to cell lineage reprogramming, providing a 'sensitized setting' for revealing cell lineage reprogramming factors that would otherwise be difficult to uncover. Additional factors, including epigenetic modifying small molecules, may be necessary for reprogramming more mature or aged differentiated cells, as previously shown in adult mice 27 .
The high variability of reprogramming efficiency among individual embryos indicates great potential in the number of differentiated cells that are amenable to induction by Oct4 and sox32 to initiate the endoderm program. Conversely, the high variability of reprogramming efficiency also indicates that there are factors and conditions yet be uncovered that may allow for more consistent and efficient induction of lineage conversion. This efficiency hurdle will need to be overcome to yield enough cells for single-cell systems analyses. Uncovering these factors to enhance lineage reprogramming will undoubtedly lead to further mechanistic insight into direct lineage conversion, both in vivo and in vitro. Testing additional reprogramming factors may also allow for induction of a distinct endoderm lineage such as pancreatic beta-cells, which will potentially have biomedical applications. Transplantation of replacement beta-cells into various locations in the body 28 , including in skeletal muscles in humans 16, 17 suggests that beta-cells can function outside their normal microenvironment to help maintain blood glucose levels. The ability to induce cells outside the foregut to adopt endoderm-like identity, as demonstrated here, is a significant step towards ultimately generating replacement beta-cells from potentially any cell type directly in the body of diabetics. Direct in vivo lineage conversion to generate replacement cells 29, 30 may bypass safety 31 and efficacy risks associated with transplantation of in vitro engineered pluripotent cells [32] [33] [34] [35] [36] . An unrestricted ability for directly reprogramming any differentiated vertebrate cells in vivo into any cell type, in any microenvironment, would greatly expand the potential therapeutic applications of direct, induced in vivo lineage conversion for regeneration medicine.
Materials and Methods:
Animal husbandry: Adult zebrafish and embryos were cared for and maintained under standard conditions. All research activity involving zebrafish was reviewed and approved by SBP Medical Discovery Institute Institutional Animal Care and use Committee (IACUC: UO1 DK105554; Expires 01/18/2021) in accordance with Public Health Policy regarding care and use of laboratory animals and comply with the Guide for the Use of laboratory Animals and the regulations set forth in the Animal Welfare Act and other applicable federal, state and local laws, regulations and policies. The following transgenic lines were used:Tg(sox17:GFP) s870 37 , Tg(gut:GFP) s854 38 , Tg(ptf1a:GFP) jh1 39 , Tg(elavl3:GFP knu3 40 ; Tg(kdrl:EGFP) s843 41 , Tg(fli1a:EGFP) y1 42 .
Transient Injections and Heat shock:
For all experiments, 0.5-1.0nl of plasmid was injected at the 1-cell stage to deliver the following amounts of plasmid DNA: hsp:H2B::mCherry-P2A-sox32 and hsp:mCherryCAAX-P2A-Oct4 (20ng) hsp:Oct4-P2A-mCherry-sox32: (30-35ng) hsp:mCherry: (30ng) mylpfa:Oct4-P2A-mCherry-sox32:(30-35ng) mylpfa:mCherry: (30ng) Antibody Staining: Antibody staining was performed as previously described 43 using the following antibodies and staining reagents: (see Supplement Materials and Methods). Samples were imaged on a Zeiss LSM710 running Zen 2010 (Black). Final image processing was performed using Image-J (vs. 1.48b) and/or Photoshop CS3.
Whole mount In situ hybridization:
In situ hybridization was performed as previously described 44 Fluorescent Whole mount In situ hybridization: Fluorescent in situ hybridization combined with immunofluorescence was performed according to published protocols [45] [46] [47] with minor modifications. Probe against vmhc was previously described (ZDB-GENE-99123-5) 48, 49 . Following hybridization, embryos were incubated with both anti-digoxigenin-POD (Roche) and chick anti-GFP antibody. In situ probe was first detected with TSA Plus fluorescein (Perkin Elmer) followed by incubation with AlexaFluor 594 donkey anti-chick secondary antibody (Invitrogen) to detect sox17:GFP localization. Stained embryos were mounted in SlowFade Gold anti-fade reagent with DAPI (Molecular Probes) prior to imaging on a Zeiss Confocal LSM710 running Zen 2010 (Black). Sample embedding: Zebrafish embryos were de-chorionated at 48hpf and transferred into a lowmelting agarose (0.6%) solution prepared with E3 medium and tricaine (Maintained at 37°C). Using a syringe and needle, samples were drawn into a cleaned FEP tube (inner diameter: 0.8mm; wall thickness: 0.4mm; Bola) and the bottom of the tube plugged with solidified 2% agarose for additional support during imaging. The plugged FEP tube was mounted on the stage assembly so that the sample was positioned vertically at the intersection of illumination and detection optical paths of the light sheet microscope. The sample chamber temperature was maintained at 28°C using a custom-built perfusion based temperature control system. Time-lapse acquisition: Samples were moved along the detection axis while being illuminated by the excitation light sheet. Images were taken every 2 microns with a high speed sCMOS camera (Zyla 4.2 PLUS, Andor) at 100 frames per second. The sample was imaged every minute and different excitation wavelengths were imaged sequentially. A typical z-stack of around 300 images was required to cover the region of interest. The overall length of the time lapse recording was approximately 16 hours, resulting in 960 individual 3D stacks in each channel.
Fluorescent Activated Cell Sorting:
To isolate single cells, fluorescence activated cell sorting (FACS) was performed on wild type embryos injected at the 1-cell stage with either mylpfa:mCherry or mylpfa:Oct4-P2A-mCherry-P2A-sox32. At 24hpf, injected embryos were placed in 0.003% phenylthiourea (PTU) to inhibit melanocyte formation and prevent pigmentation. At 48hpf, embryos were inspected and only healthy/developmentally normal embryos were manually dechorionated. Following collection in 1.5ml eppi tubes, pooled embryos were washed in 1xPBS, incubated in 1xPBS(+Mg/Ca; )+ 0.05 mg/ml Liberase TM (Roche) at 37°C for 60 min and triturated with a P1000 pipette. The resulting suspension was filtered with a 30μm Celltrics cell strainer (Sysmex), spun down (300g for 10min at 4°C) and resuspended in ice cold 1xPBS +0.9% FBS(Gibco). SYTOX Red (Thermo Fischer Scientific) was added at 1:1000 to exclude dead cells immediately prior to sorting for either qPCR analysis or quantification of induction efficiency.
Quantitative PCR: For qPCR experiments, cells were sorted with a FACSAria II (BD Biosciences). Following FACS, sorted cells were homogenized with a QIAshredder (QIAGEN)and total RNA extracted using the RNeasy Mini Kit (Qiagen). cDNA was synthesized using i-Script Supermix (Bio Rad) and qPCR performed using iQ SYBR Green Supermix (Bio Rad) according to manufacturer protocols. Samples were loaded on a 384 well plate and analyzed on an ABI 7900HT (Applied Biosystems). Primers to detect zebrafish transcripts were designed and are described in Supplement Material and Methods. Relative expression levels of genes were calculated by the following formula: relative expression = 2−(Ct[gene of interest] −Ct[housekeeping gene]). To test statistical significance, the non-parametric Mann-Whitney test was performed (2-tailed, 95% confidence interval).
Reporter Induction Efficiency:
To analyze reporter induction efficiency, sox17:GFP, elav3:GFP, or fli1a:GFP embryos were injected with either mylpfa:mCherry or mylpfa:Oct4-P2A-mCherry-P2A-sox32. Upregualtion of fluorescent reporters was quantified by performing FACS using a BD LSRFortessa X-20 (BD Biosciences). Data was analyzed with FlowJo V-10 (FlowJo, LLC). Percent induction efficiency was determined using the following formula: (total number of GFP+ and mCherry+ Cells)/(total number of mCherry+ cells) x 100. Error was determined using the percentage of GFP+ and mCherry+ cells obtained from each respective reporter line injected with mylpfa:mCherry. SU5402 treatment: 3μM SU5402 (sc-204308; Santa Cruz Biotechnology) was added to egg water with 1%DMSO and incubated 24-48 hpf.
Expression Constructs:
Cloning details and sequence available upon request for the following: Hsp:Oct4-P2A-mCherryCAAX;Alpha-Crystallin:dsRed, Hsp70:H2B::mCherry-P2A-Cas32; Cmlc2:dsRed, Hsp70:Oct4-P2A-mCherry-P2A-sox32; Alpha-Crystallin:dsRed, Hsp70:Oct4(L80A)-P2A-mCherry-P2A-sox32; Alpha-Crystallin:dsRed, Hsp70:mCherry; Alpha-Crystallin:dsRed, mylpfa:Oct4-P2A-mCherry-P2A-sox32; Alpha-Crystallin, mylpfa:mCherry; Alpha-Crystallin. Oct4 was cloned from FUW-OSKM, a gift from Rudolf Jaenisch (Addgene plasmid # 20328 ; http://n2t.net/addgene:20328 ; RRID:Addgene_20328) 50 . 3D rendering of 72 hpf ptf1a:GFP zebrafish myotomes from embryos injected with either hsp:mCherry or hsp:Oct4-P2A-mCherry-P2A-sox32 and treated with either the vehicle DMSO (A, C) or the FGFR kinase inhibitor SU5402 (B, D) . DMSO treatment did not affect reprogramming outcomes in the ptf1a:GFP background following induction of control hsp:mCherry (A-A": +ectopic ptf1a:GFP; n=0/118) compared to SU5402 treated controls (B-B": n=0/106). Note that DMSO also has no effect on normal exocrine pancreas development, marked by ptf1a:GFP (green; inset A", C") or pancreatic endocrine beta cell development, labelled with Insulin (white; inset A", C"). DMSO treatment did not impact reprogramming efficiency with hsp:Oct4-P2A-mCherry-P2A-sox32, in ptf1a:GFP transgenics (C-C": n=27/121).
However, SU5402 did strongly inhibit ptf1a:GFP induction in myocytes expressing Oct4 and 
